Robert F. Williamson III

President & Chief Executive Officer at BioTheryX, Inc.

Robert F. Williamson III

Robert F. Williamson III

President & Chief Executive Officer at BioTheryX, Inc.

Overview
Career Highlights

EOS Biotechnology, Inc.
DoubleTwist, Inc.
Strategic Enzyme Applications, Inc.

RelSci Relationships

1738

Number of Boards

7

Birthday

1966

Age

55

Relationships
RelSci Relationships are individuals Robert F. Williamson III likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder, Chief Development Officer & Chairman & Owner at BioTheryX, Inc.

Relationship likelihood: Strong

Co-Founder at Presidio Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Clarke Industrial Engineering, Inc.

Relationship likelihood: Strong

Chairman at Clarke Industrial Engineering, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at DoubleTwist, Inc.

Relationship likelihood: Strong

Chairman at The Boston Consulting Group, Inc.

Relationship likelihood: Strong

Chief Executive Officer at The Boston Consulting Group, Inc.

Relationship likelihood: Strong

Senior Partner & Managing Director at The Boston Consulting Group, Inc.

Relationship likelihood: Strong

Former Senior Vice President, Research at BrainCells, Inc.

Relationship likelihood: Strong

Charles Howard Candler Professor of Law Emeritus at Emory University - School of Law

Relationship likelihood: Strong

Paths to Robert F. Williamson III
Potential Connections via
Relationship Science
You
Robert F. Williamson III
President & Chief Executive Officer at BioTheryX, Inc.
Education
Undergraduate

Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA

Stanford University, officially Leland Stanford Junior University, is a private research university in Stanford, California. Stanford was founded in 1885 by Leland and Jane Stanford in memory of their only child, Leland Stanford Jr., who had died of typhoid fever at age 15 the previous year. Stanford is generally ranked among the best universities in the world by academic publications. It is also one of the top fundraising institutions in the country, becoming the first school to raise more than a billion dollars in a year.

MBA

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History
President & Chief Executive Officer
2021 - Current

BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.

Founder
2002 - Current
President & Chief Operating Officer
2002 - ?

EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California.

Boards & Committees
Non-Executive Director
2008 - 2009

TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.

Director
2004 - Prior

Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.

Chief Executive Officer & Director
2004 - 2006

Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications.Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California.

Transactions
Details Hidden

PharmAkea, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert F. Williamson III. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert F. Williamson III's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert F. Williamson III.